February 11 is the International Day of Women and Girls in Science. To mark the occasion, we asked our community of female scientists to tell us about their women in science hero who encouraged them and how they hope to inspire the next generation of girls to pursue science.
Mosquito-transmitted diseases affect an estimated 347.8 million people annually and are responsible for nearly 450,000 deaths each year, making them one of the most dangerous animals in the world. Despite their devastating impact, research on the mosquito has lagged behind that of other model organisms, in part due to the lack of appropriate tools and resources. Kathryn Rozen-Gagnon is trying to change that. Read more about how she is integrating diverse fields to study the interplay between mosquito-borne viruses and their mosquito and human hosts.
Researchers from the University of Toronto and Nigerian Institute of Medical Research have received $3 million from the federal government to launch an international project that will help inform the clinical and public health response to local and global epidemic of mpox. The new funding from the Canadian Institutes of Health Research (CIHR) and International Development Research Centre builds on the collaborative projects and seed funding from the mpox rapid research response launched by EPIC earlier this year.
On World AIDS Day, we spotlight eight talented trainees who are doing impactful work on HIV/AIDS.
As the global health and research communities mark World Antimicrobial Awareness Week, members of the Emerging and Pandemic Infections Consortium (EPIC) are making strides in the fight against antimicrobial resistance. L
The Emerging and Pandemic Infections Consortium (EPIC) is pleased to introduce its inaugural steering committee. Meet the 12 members of our steering committee!
September 19 to 25 marks Science Literacy Week in Canada, an opportunity to showcase how science, discovery and ingenuity shape our lives. The theme for Science Literacy Week 2022 is mathematics so we decided to sit down with two young scientists to talk about mathematical modelling of infectious diseases and their own personal work in that area.
By Rahul Kalvapalle The University of Toronto and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Guided by a partnership framework agreement, the U.S. biotechnology firm...
The Toronto High Containment Facility (THCF), housed at the University of Toronto’s Temerty Faculty of Medicine, is equipped to safely study pathogens that cause infectious disease, and was among the first labs in Canada to enable researchers to work with SaRS-CoV-2 samples.
While similar facilities elsewhere had closed after the 2003 SARS outbreak, the U of T lab remained open – supporting a vast research community including academic, hospital and industrial research needs – and was able to make a significant contribution to understanding and addressing the COVID-19 pandemic.
Originally published on the University of Toronto Rahul Kalvapalle Two projects involving researchers at the University of Toronto and its partner hospitals, each aimed at better understanding and tackling COVID-19, have been awarded a combined total of nearly $2.5...
Related page →
Link to resource →
Contact us CTA →